Clinical Trial Update: Developing Resiliency and Exercise Using AI-based Messaging [NA]

View source ↗

Summary

Massachusetts General Hospital is updating a planned clinical trial evaluating resiliency and exercise using AI-based messaging for Diabetes Mellitus Type 2. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Diabetes Mellitus Type 2 | NA | Status: NOT_YET_RECRUITING